COVID 19 Seroprevalence Amongst Healthcare Workers in JHAH

Johns Hopkins Aramco Healthcare

Status: Unknown

Conditions: COVID 19

Treatments: Diagnostic Test: Serology Test

Study type: Observational

Funder types: Other

Identifiers

NCT04469647

IRB20-09

Details and patient eligibility

About

Healthcare workers play a critical role in fighting the pandemic, not only by managing the patients' health clinically, but also by implementing adequate measures for infection prevention and control in healthcare facilities. This puts healthcare workers at a greater risk of acquiring the disease. COVID-19 is caused by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2) and many people can be infected with it asymptomatically and undetectably.

Serology is an antibody test that provides additional information to polymerase chain-reaction (PCR) testing as it is the only way to reliably establish the fraction of the population that was infected . Seroconversion is the development of antibodies in the blood which can confirm suspected cases after the fact and reveal who was infected but asymptomatic and never realized it. Antibodies are specific proteins created as the body's response to the infection and this test is essential for detecting infected individuals with few or no symptoms at all.

Enrollment: 1,200 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. Adult.
2. JHAH employee
3. Housekeepers (this group of staff are outsourced at JHAH)

Exclusion criteria

1. Any participant exhibiting COVID 19 symptoms

Trial design

1,200 participants in 2 patient groups

High-risk

Description:

Employees at high-risk of Coronavirus exposure areas (physicians, nurses, respiratory therapists, radiology technologists, lab technologists, housekeepers)

Treatment:

Diagnostic Test: Serology Test

Low-risk

Description:

Employees working at lower risk areas such as (administration, HR, Public relations)

Treatment:

Diagnostic Test: Serology Test